前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202102290665318090
整理番号：21A0898396
免疫細胞シグネチャーは切除可能胃癌患者の無病生存およびアジュバント化学感受性と関連する【JST・京大機械翻訳】
An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer
Yan Hongfei
(1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China)
,
Yan Hongfei
(2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China)
,
Yan Hongfei
(3Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, China)
,
Yan Hongfei
(4Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, China)
,
Chen Yang
(2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China)
,
Chen Yang
(5Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China)
,
Yang Zichang
(1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China)
,
Yang Zichang
(2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China)
,
Yang Zichang
(3Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, China)
,
Yang Zichang
(4Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, China)
,
Li Zhi
(1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China)
,
Li Zhi
(2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China)
,
Li Zhi
(3Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, China)
,
Li Zhi
(4Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, China)
,
Che Xiaofang
(1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China)
,
Che Xiaofang
(2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China)
,
Che Xiaofang
(3Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, China)
,
Che Xiaofang
(4Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, China)
,
Xiao Jiawen
(6Department of Medical Oncology, Shenyang Fifth People Hospital, Shenyang, China)
,
Liu Yunpeng
(1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China)
,
Liu Yunpeng
(2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China)
,
Liu Yunpeng
(3Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, China)
,
Liu Yunpeng
(4Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, China)
,
Qu Xiujuan
(1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China)
,
Qu Xiujuan
(2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China)
,
Qu Xiujuan
(3Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, China)
,
Qu Xiujuan
(4Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, China)
資料名：
Frontiers in Immunology (Web)
(Frontiers in Immunology (Web))
巻： 11 ページ： 621623 発行年： 2020年
JST資料番号： U7074A ISSN： 1664-3224 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： スイス (CHE) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。